Biovest International Overview
- Year Founded
-
1993
- Status
-
Private
- Employees
-
51
- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$5.6M
Biovest International General Information
Description
Developer of cancer vaccines and biotechnology products. The company develops active personalized immunotherapy that targets cancers of the blood system. It also markets hollow fiber bio-production instruments and provides custom cell-culture services, including contract manufacturing. The company's lead personalized cancer vaccine is BiovaxID, which it is developing as a treatment for late-stage non-Hodgkins lymphoma.
Contact Information
Website
www.cellculturecompany.comCorporate Office
- 8500 Evergreen Boulevard
- Coon Rapids, MN 55433
- United States
Corporate Office
- 8500 Evergreen Boulevard
- Coon Rapids, MN 55433
- United States
Biovest International Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. PIPE | 15-Jul-2013 | $5.6M | Completed | Bankruptcy: Admin/Reorg | ||
| 11. Bankruptcy: Admin/Reorg | 07-Mar-2013 | Completed | Bankruptcy: Admin/Reorg | |||
| 10. Debt - General | 24-Feb-2011 | Completed | Generating Revenue | |||
| 9. Grant | 04-Nov-2010 | Completed | Generating Revenue | |||
| 8. Convertible Debt | 25-Oct-2010 | Completed | Generating Revenue | |||
| 7. Bankruptcy: Admin/Reorg | 01-Jan-2009 | Completed | Generating Revenue | |||
| 6. Convertible Debt | 22-Sep-2008 | Completed | Bankruptcy: Admin/Reorg | |||
| 5. PIPE | Completed | Generating Revenue | ||||
| 4. PIPE | 19-Dec-2006 | $363K | $363K | Completed | Generating Revenue | |
| 3. Buyout/LBO (Add-on) | 30-Jun-2003 | $20M | $1M | Completed | Generating Revenue |
Biovest International Patents
Biovest International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150259749-A1 | Methods for producing high-fidelity autologous idiotype vaccines | Active | 31-Aug-2012 | ||
| US-9725768-B2 | Methods for producing high-fidelity autologous idiotype vaccines | Active | 31-Aug-2012 | ||
| WO-2014036488-A1 | Methods for producing high-fidelity autologous idiotype vaccines | Inactive | 31-Aug-2012 | ||
| CA-2920957-A1 | Biomanufacturing suite and methods for large-scale production of cells, viruses, and biomolecules | Inactive | 28-Aug-2012 | ||
| EP-2909302-A1 | Biomanufacturing suite and methods for large-scale production of cells, viruses, and biomolecules | Inactive | 28-Aug-2012 | C12M23/44 |
Biovest International Signals
Biovest International FAQs
-
When was Biovest International founded?
Biovest International was founded in 1993.
-
Where is Biovest International headquartered?
Biovest International is headquartered in Coon Rapids, MN.
-
What is the size of Biovest International?
Biovest International has 51 total employees.
-
What industry is Biovest International in?
Biovest International’s primary industry is Drug Discovery.
-
Is Biovest International a private or public company?
Biovest International is a Private company.
-
What is Biovest International’s current revenue?
The current revenue for Biovest International is .
-
How much funding has Biovest International raised over time?
Biovest International has raised $15.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process